Hematology

>

Latest News

Neupogen Biosimilar Nivestym Matches Efficacy for Allogeneic HSCT Donor Mobilization
Neupogen Biosimilar Nivestym Matches Efficacy for Allogeneic HSCT Donor Mobilization

December 5th 2023

A single-center cohort analysis showed the biosimilar provided similar PBSC mobilization to originator filgrastim.

Hydroxyurea Treatment Associated with Improving Sickle Cell Disease in Children
Hydroxyurea Treatment Associated with Improving Sickle Cell Disease in Children

November 10th 2023

Doctor holding infant | Credit: Sanity
Study Details AKI Prevalence, Risk Factors in Infant Liver Transplant Patients

November 9th 2023

US FDA logo in black over a white background | Credit: US Food and Drug Administration
FDA Approves Adzynma for Congenital Thrombotic Thrombocytopenic Purpura

November 9th 2023

Study Explored High Prevalence of Anemia in Children Under 5 Years Old in Ghana
Study Explores High Prevalence of Anemia in Children Under 5 Years Old in Ghana

November 9th 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.